» Articles » PMID: 26210522

Epidemiology of New-onset Paroxysmal Atrial Fibrillation in the General Intensive Care Unit Population and After Discharge from ICU. A Retrospective Epidemiological Study

Overview
Date 2015 Jul 27
PMID 26210522
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Evidence of various cardiac arrhythmias in septic patients has been demonstrated by multiple clinical reports and observations. Most cardiac arrhythmias in sepsis are new-onset and may be related to sepsis-induced myocardial dysfunction. We propose to investigate and analyze data of new-onset paroxysmal atrial fibrillation (AF) in a critically ill septic population.

Methods: This is a retrospective epidemiologic study. We collected clinical data from two hundred septic patients who developed a new episode of atrial fibrillation during their hospitalization in General Intensive Care Unit (GICU) between January 2007 and June 2013.

Results: Of these 200 septic patients, 81 septic patients developed a new episode of AF and included in the present study. Thirty-seven patients had no past medical history of atrial fibrillation (AF) or antiarrhythmic therapy (new episode of atrial fibrillation, Group 1) and 44 had previously known episodes of atrial fibrillation and were prescribed antiarrhythmic therapy at home (Group 2). Group 2 patients had longer duration of recurrent episodes of atrial fibrillation compared to patients in Group 1 (11.07 ± 8.7 vs. 7.4 ± 6.1 days; P = 0.013). The overall ICU and in-hospital mortality rate was similar in both study groups. There was no significant difference in new stroke and pulmonary embolism (PE) between both study groups (P > 0.05).

Conclusion: In the present study we demonstrated no difference in morbidity and mortality rate in-ICU and after discharge between septic patients who had previous AF episodes and patients who had no previous past medical history of any cardiac arrhythmias.

Citing Articles

Prevalence, Risk Factors, and Mortality of New-Onset Atrial Fibrillation in Mechanically Ventilated Critically Ill Patients.

Zakynthinos G, Tsolaki V, Xanthopoulos A, Karavidas N, Vazgiourakis V, Bardaka F J Clin Med. 2024; 13(22).

PMID: 39597893 PMC: 11595098. DOI: 10.3390/jcm13226750.


The Significance of Inflammation in Atrial Fibrillation.

Rachieru C, Lighezan D, Petrescu L, Tartea G, Goanta E, Buzas R Curr Health Sci J. 2024; 50(1):59-66.

PMID: 38846471 PMC: 11151943. DOI: 10.12865/CHSJ.50.01.08.


Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology.

Dobrev D, Heijman J, Hiram R, Li N, Nattel S Nat Rev Cardiol. 2022; 20(3):145-167.

PMID: 36109633 PMC: 9477170. DOI: 10.1038/s41569-022-00759-w.


Prevalence of New-Onset Atrial Fibrillation and Associated Outcomes in Patients with Sepsis: A Systematic Review and Meta-Analysis.

Corica B, Romiti G, Basili S, Proietti M J Pers Med. 2022; 12(4).

PMID: 35455662 PMC: 9026551. DOI: 10.3390/jpm12040547.


Clinical prediction scores and early anticoagulation therapy for new-onset atrial fibrillation in critical illness: a post-hoc analysis.

Sakuraya M, Yoshida T, Sasabuchi Y, Yoshihiro S, Uchino S BMC Cardiovasc Disord. 2021; 21(1):423.

PMID: 34496749 PMC: 8424957. DOI: 10.1186/s12872-021-02235-8.